Peptides became the word the grooming industry reached for when it ran out of other words. Every serum on a shelf now contains them, every brand claims to have the right combination, and the man standing in front of the display has no reliable way to know which bottle is doing real work and which is doing real marketing. The confusion is not accidental. Peptides are a legitimate class of compounds with genuine mechanisms — but the gap between what the science supports and what the packaging claims is wide enough to lose several years of protocol in.

What follows is what the evidence actually says.
What a peptide is, precisely.
A peptide is a short chain of amino acids — fewer than fifty, usually fewer than twenty — linked by peptide bonds. Proteins are also amino acid chains, but longer ones. The distinction matters because size determines penetration. A full protein molecule cannot pass through the stratum corneum; a short peptide, depending on its structure and the vehicle it is delivered in, often can.1 This is the biological basis for using peptides topically rather than simply applying protein.
The scalp and hair follicle are responsive to a class of small signalling molecules, and certain peptides mimic or modulate those signals. The mechanism is not magic and it is not marketing — it is receptor binding. The question is always whether a given peptide reaches its target at a concentration sufficient to produce a measurable effect, and whether the delivery system in the product supports that.2
The three categories worth knowing.
Signal peptides instruct cells to behave differently. The most studied in hair and scalp applications is copper peptide GHK-Cu, a naturally occurring tripeptide that accumulates around follicles and has been shown in controlled work to extend the anagen (growth) phase, increase follicle size, and stimulate both keratinocyte proliferation and vascular endothelial growth factor — the signal responsible for building new blood vessels around the follicle base.3 It does not grow hair where follicles are absent. It supports and extends the function of follicles that are present but underperforming.
Carrier peptides transport trace elements — typically copper or manganese — into the dermis at concentrations that would be toxic or unstable if delivered as free minerals. GHK-Cu is also the primary carrier peptide in scalp applications, which is why it appears in both categories. The copper it delivers is a cofactor in enzymes responsible for collagen synthesis and tissue repair in the dermis surrounding the follicle.4
Neurotransmitter-inhibiting peptides — Argireline (acetyl hexapeptide-3) and its relatives — work by reducing muscle contraction signals at the neuromuscular junction. Their primary application is facial antiaging; their relevance to the scalp is limited. Products that lead with these peptides for a scalp protocol are prioritising ingredient recognition over mechanism.5
Multi-peptide formulations — what the combination actually does.
A multi-peptide serum is only as good as its delivery system and its concentration ratios. Combining five peptides at concentrations too low to cross the stratum corneum individually does not produce a synergistic effect; it produces an expensive list of ingredients. The variable that separates working multi-peptide formulations from decorative ones is usually the vehicle — the lipid or encapsulation system that carries the peptide past the skin barrier — rather than the number of peptides named on the label.6
The combinations with the strongest evidence for scalp use pair GHK-Cu with one of two other agents: biotinoyl tripeptide-1, which has shown direct stimulation of follicle anchorage proteins in vitro,7 or acetyl tetrapeptide-3, which acts on the extracellular matrix components that anchor the follicle to the dermis.8 These combinations address the follicle from three directions — growth phase extension, structural anchorage, and dermal support — without redundancy.
Where men go wrong is in layering too many actives at once and then being unable to identify what is working. A peptide serum applied on top of a low-pH acid has its activity degraded by pH competition. Applied after a silicone-based styling product, it cannot reach the scalp surface. The delivery context matters as much as the formula.9
Peptides alongside minoxidil and finasteride.
For men already using clinically established hair retention protocols, peptides are additive rather than alternative. Minoxidil works primarily by extending anagen and increasing follicle blood supply; GHK-Cu acts on overlapping but not identical pathways, which is why the combination is rational rather than redundant.10 Finasteride addresses DHT-mediated miniaturisation at the hormonal level; peptides operate downstream, at the structural and cellular level of the follicle itself. They are not competing interventions.
The one caution: adding a new active to an existing protocol makes it harder to attribute change. If the protocol is working, adding peptides should be done as a deliberate, tracked introduction rather than a simultaneous change alongside anything else.
What a reasonable protocol looks like.
A single well-formulated GHK-Cu or biotinoyl tripeptide-1 serum, applied to a clean, dry scalp, massaged in for sixty to ninety seconds to encourage dermal absorption, used consistently five to seven days a week — that is the protocol. The massage component is not optional decoration: mechanical stimulation of the scalp increases dermal blood flow and has independent evidence for follicle support.11 It also improves the absorption window for whatever is applied immediately after.
More products do not mean more results. The stack should be the minimum that addresses the mechanism. Anything beyond that is increasing cost and complexity without increasing signal.
A protocol built on your actual scalp condition, hair density, and existing actives is different from a protocol built on ingredient lists. Members get the former.
Request a ConsultationWhen peptides are not the answer.
Peptides work on follicles that are present and functional but underperforming. They do not reverse advanced miniaturisation where follicles have fully closed. They do not address active scalp inflammation — applying a peptide serum to an irritated, flaking, or infected scalp introduces another variable into an environment that first needs to be stabilised. The baseline described in Scalp Health, Quietly is the prerequisite, not the afterthought. A compromised barrier reduces peptide penetration regardless of formulation quality.12
For men experiencing active thinning, peptides are one part of a considered response, not the whole response. Thinning Without the Panic covers the fuller picture — what thinning is, what it is not, and the hierarchy of interventions that evidence supports.